Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease

Who May Qualify: - Patients diagnosed with type 2 diabetes and NAFLD - Age between 18 and 75 years - BMI between 18.0 and 35.0 kg/m2 - Weight stable for at least 3 months prior to the study (gain or loss \< 4 kg) - Stable treatment for at least 3 months with 1-3 oral antidiabetic medications (with or without insulin therapy), or not yet received antidiabetic medication prior to the beginning of the study - Able to give written willing to sign a consent form Who Should NOT Join This Trial: - Self-reported a food allergy - Alcohol abuse in the last 3 months (alcohol intake greater than 20 g per day for women; Alcohol intake for men greater than 40 g per day) - Other liver diseases such as chronic hepatitis B and C, autoimmune hepatitis, primary biliary cirrhosis, hemochromatosis, nodular regenerative hyperplasia and focal nodular hyperplasia - Scheduled to be hospitalized for any surgical treatment during screening - Pregnant or planning of pregnancy during the study - Inability, physically or mentally, to adhere the procedures required by the study protocol - Level 3 hypoglycemic events (at least 3 times) occurring within the 90 days prior to screening - Hospitalization or emergency department visit for hyperglycemia, diabetic ketoacidosis, lactic acidosis, hyperosmolar nonketotic coma, or diabetes - History of cancer within the past 5 years - Acute coronary or cerebrovascular event in the past 90 days, or heart failure - Hemorrhagic or ischemic stroke within the last 6 months Always talk to your doctor about whether this trial is right for you.